Literature DB >> 19148472

Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes.

Ayguen Sahin1, Chantal Vercamer, Annette Kaminski, Tanja Fuchs, Alexandra Florin, Jens Claus Hahne, Virginie Mattot, Albin Pourtier-Manzanedo, Torsten Pietsch, Véronique Fafeur, Nicolas Wernert.   

Abstract

We previously reported that the inactivation of the Ets 1 transcription factor by a specific decoy strategy reduces rat C6 glioma cell proliferation and mmp-9 expression. In the present study, we analysed the effects of the dominant-negative form of Ets 1 (Ets-DB) on rat C6 glioma cell proliferation, migration, invasion, in vivo tumor growth on the chicken chorioallantoic membrane (CAM) and mmp-9 expression. In addition, we examined differences in gene expression between Ets-DB expressing and control cells using suppression subtractive hybridization (SSH). We found that retrovirus mediated expression of Ets-DB inhibited cellular proliferation, migration, invasion, mmp-9 expression, cellular growth in soft agar, and in vivo growth in the chicken chorioallantoic membrane assay. SSH analysis revealed expression of different genes in Ets-DB expressing cells involved in basic cellular processes. Each of these genes contained binding sites for different Ets-factors within their promoters. Finally, we found that, in addition to Ets 1, Elk-1, Elf-1, Fli-1 and Etv-1 are further Ets family members expressed in rat C6 glioma cells. Our results indicate that Ets transcription factors play important roles for basic properties of rat C6 glioma cells. Targeting of these factors might therefore become a useful experimental tool for therapeutic strategies against malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148472

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  HGF upregulates CXCR4 expression in gliomas via NF-kappaB: implications for glioma cell migration.

Authors:  Mine Esencay; Elizabeth W Newcomb; David Zagzag
Journal:  J Neurooncol       Date:  2010-02-16       Impact factor: 4.130

2.  The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage.

Authors:  Niall Kerr; Alexander Pintzas; Fiona Holmes; Sally-Ann Hobson; Robert Pope; Mark Wallace; Christine Wasylyk; Bohdan Wasylyk; David Wynick
Journal:  Mol Cell Neurosci       Date:  2010-03-18       Impact factor: 4.314

3.  Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.

Authors:  Velidi H Rao; Vikrant Rai; Samantha Stoupa; Devendra K Agrawal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

4.  The differential disease regulome.

Authors:  Geir K Sandve; Sveinung Gundersen; Halfdan Rydbeck; Ingrid K Glad; Lars Holden; Marit Holden; Knut Liestøl; Trevor Clancy; Finn Drabløs; Egil Ferkingstad; Morten Johansen; Vegard Nygaard; Eivind Tøstesen; Arnoldo Frigessi; Eivind Hovig
Journal:  BMC Genomics       Date:  2011-07-07       Impact factor: 3.969

5.  Transcription factor PU.1 is involved in the progression of glioma.

Authors:  Yuanzhi Xu; Song Gu; Yunke Bi; Xiangqian Qi; Yujin Yan; Meiqing Lou
Journal:  Oncol Lett       Date:  2018-01-10       Impact factor: 2.967

6.  Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1.

Authors:  David Adler; Andreas Lindstrot; Reinhard Buettner; Nicolas Wernert
Journal:  Oncol Lett       Date:  2011-12-02       Impact factor: 2.967

7.  ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.

Authors:  David Adler; Jacqueline Ochsenfahrt; Kerstin Fuchs; Glen Kristiansen; Sven Perner; Nicolas Wernert
Journal:  Int J Mol Med       Date:  2012-08-20       Impact factor: 4.101

8.  PAX3 and ETS1 synergistically activate MET expression in melanoma cells.

Authors:  J D Kubic; E C Little; J W Lui; T Iizuka; D Lang
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

9.  Ets-1 global gene expression profile reveals associations with metabolism and oxidative stress in ovarian and breast cancers.

Authors:  Meghan L Verschoor; Chris P Verschoor; Gurmit Singh
Journal:  Cancer Metab       Date:  2013-07-25

10.  miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.

Authors:  Si-Yi Zhang; Zhong-Ming Lu; Ye-Feng Lin; Liang-Si Chen; Xiao-Ning Luo; Xin-Han Song; Shao-Hua Chen; Yi-Long Wu
Journal:  Oncotarget       Date:  2016-03-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.